Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic specialty Therapies (Neurovascular, ENT & Pelvic Health) — International Foreign Currency Impact ($M) ($M)
Medtronic Form 8-K International Revenue Tables
Latest, FY2026
49
Period ended Apr 30, 2026
Change on a year earlier
-388.2%
-17 in FY2025
History
2 years
Since FY2025
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Specialty Therapies (Neurovascular, ENT & Pelvic Health) — International Foreign Currency Impact ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2026 | Apr 30, 2026 | 49 | -388.2% | Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗ |
| FY2025 | Apr 30, 2025 | -17 | – | Medtronic SEC 8K_EARNINGS — FY2025Q4 (filed 2025-05-21) ↗ |
Cite this data
StockData. (2026). Medtronic Specialty Therapies (Neurovascular, ENT & Pelvic Health) — International Foreign Currency Impact ($M) ($M), annual FY2025–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/neuro-st-intl-fx
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.